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Gastroscopic Findings and Fecal Blood Loss 
Following Aspirin Administration 
DONALD H. KUIPER, MD, BERGEIN F. OVERHOLT, MD,* 
DANIEL J. FALL, M D ,  a n d  H.  ~IARVIN POLLARD, ~'ID 
A study of 19 heahhy  young male subjects (Group l) was made in which a 
correlat ion of aspirin ingestion, fecal b lood loss, blood salicylate levels, 
p ro th rombin  concentrat ions,  and A B O  blood groups was sought. An init ial  
.I-day control  per iod was fol lowed by a 4-dav test per iod  du r ing  which 
subjects ingested 650 mg aspirin with each meal  and at bedt ime.  Gastroscopy 
with photography was done on Day 1 and Day 7. Daily fecal blood loss was 
quant i ta ted  .using the 51-chromium tagged erythrocyte method.  Sixteen 
pat ients  (Group 2) with a variety of uppe r  gastrointest inal  disorders under-  
went  gastroscopy and photography  before and after  the acute ingest ion of 
aslfirin. Results reveal: (1) Aspir in  produced  petechiae  in 4 of 18 subjects 
and a hemorrhagic  gastritis in 1 of 18 in Group  I, (2) aspir in produced  no 
visible lesions in the 16 subjects in Group  2, (3) the mean  fecal b lood loss 
dur ing  the control  per iod  was 0.38±0.35 g/24 h r  and rose to 1.54-----1.42 g /  
24 hr  (p ~ 0.01) ( luring aspirin ingestion, (4) no corre la t ion between normal  
or abnormal  gastroscopic findings and fecal b lood loss was apparent ,  and 
(5) no corre la t ion be tween blood salicylate levels, p ro th rombin  concentra- 
tions, and gastroscopic findings or  fecal blood loss was detected. 
M aNy S'rL'D1ES have been carried out in both health) volunteers and patients ill order to define the effect of aspirin upon the human stomach. 
Endoscopic studies done following the ingestion of aspirin have provided 
conllicting results concerning the lesion induced by aspirinA -T These results 
have depended upon the variable experimental  conditions and the patient's 
underlying illness. It  is clear, however, that aspirin does increase the fecal 
blood loss in normal and abnormal subjects, s-l° 
To  our  knowledge, no study has measured fecal blood loss ill tile same 
group of subjects who were evaluated by gastroscopy. It is tile purpose of 
this communication to present tile results of fecal blood loss and gastroscopic 
findings in a group of healthy volunteers during a control period and after 
a period of aspirin ingestion. In addition, gastroscopic data are presented from 
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a group of patients with gastrointestinal disorders, following the acute 
ingestion of aspirin. 
METHODS 
GROUP ] 
Nineteen healthy volunteers, ages 21-29 years, were studied in the Glinical 
Research Unit of our hospital. A history and physical examination were 
performed routinely. All subjects denied previous gastrointestinal disease or 
intolerance to aspirin. Following the base line studies (indicated at the 
bottom of Table 1), a gastroscopy with the Olympus GTF gastrocamera was 
performed 30 min after preparation using meperidine hydrochloride, 75-100 
rag; atropine, 0.4 rag; pentobarbital, 100 rag; simethicone, 6 drops; and 2~o 
viscous lidocaine, topically. Two endoscopists independently examined each 
stomach. Appropriate photographs were taken of each stomach. Following 
the gastroscopy, 20.0 ml of the patient's whole blood was mixed with 6.0 ml 
acid citrate dextrose solution and was then incubated with 100 /~c of sodium 
chromate-51 at 37.0°C for 120 rain. Using this procedure, approximately 
95% of the erythrocytes were tagged with the isotopeA ~ The tagged cells were 
then reinjected. 
TABLE 1. CLINICAL DATA IN GROUP 1 SUBJECTS 
Post-aspb'in Mean fecal blood loss (0/24 hr) 
Blood gaslroseopy 
Subject group .4 ge findings Control period Test peried 
R.S. A - 22 2 petechiae lesser curve < 0.25 0.83 
antrum 
S.H. 0 - 23 3 petechiae lesser cucve 0.48 2.40 
antrum 
T.G. Aq- 22 Diffuse hemorrhagic 0.29 0.25 
gastritis 
A.P. A q- 25 1 petechial hemorrhage 0.69 2.24 
lesser curve antrum 
R.C. Aq- 21 Mult  petechiae greater 0.30 0.7~ 
e~trve antrum 
C.V. Oq- 25 Normal 0.40 1.14 
E.A. A q- 23 Normal < 0.25 6.26 
L.A. AB q- 24 Normal 0.59 1.4.5 
F. t l .  A q- 25 Normal 0.52 2.00 
C.P. 0 q- 25 Normal < 0.25 0.94 
B.D. 0 + 2q Normall 0.74 I .  57 
B.G. AB q- 24 Normal " 0.40 2.03 
E.T. A q- 24 Normal I < 0.25 0.46 
M.S. O Jr- 24 Normal ] 0.33 0.62 
J.L. A q- 24 Normal < 0.25 I. 01 
1).B. 0 q- 26 Normal < 0.25 0.72 
T.K. B - 26 Normal ' Hemolyzed Hemolyzed 
L.C. A q- 25 Normal Epistaxis Epistaxis 
R.~'.* A q- 29 Normal <0.25 0.45 
*Receixed placebo. Baseline studies: Hematocrit. WBC. urine analysis, BUN. prothrombin 
time. 
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Individual 24-hr fecal collections w e r e  made throughout  the study, using 
tarred glass containers. All subjects were instructed to avoid urine contamina- 
tion of the fecal collections. A 4-day control period was initiated on the day 
of admission. This was followed by a 4-day test period in which all subjects 
ingested 650 mg of hospital-prepared aspirin* with each meal and at bedtime 
each day. All were fed a general diet and abstained from alcohol. Activity 
was not restricted. The  only medication administered was Metamucil (psyllium 
hydrophilic muci l lo id) , t  1 tablespoon, with 4 oz of water at 8 AM and 5 PZ~t 
daily in order to avoid constipation. On the morning of Day 7 (after 2 days 
of aspirin ingestion), each subject again underwent gastroscopy 30-45 rain 
following the ingestion of 650 mg aspirin on the fasting stomach. Prothrombin 
concentrations were again drawn on Day 3 of the test period. Daily blood 
salicylate levels were determined on each subject using the ferric chloride 
method. 12 
Employing the ashing technic, 24-hr stool samples were radio assayed. With 
this technic, 0.25 g of whole blood may be detected in a 24-hr stool with an 
error of less than 8% when stool samples are counted for 10 min. An upper 
gastrointestinal X-ray with a small bowel follow-through, done the day 
following the test, was normal in all subjects. 
GRouP 2 
Sixteen patients with a variety of upper gastrointestinal disorders including 
gastric ulcer, gastric carcinoma, gastric mucosal atrophy, and marginal ulcera- 
tion, underwent gastroscopy and photography shortly before and after aspirin 
ingestion. This was done after preparation as described in Group 1 except 
that 4% cocaine was employed as a topical anesthetic. 
In Group 2A (10 patients), immediately following initial endoscopy and 
photography, the patients were given two 325-mg hospital-prepared aspirin 
tablets with 1-2 oz water. The  patient was then instructed to lie on his back. 
A gastroscopy with photography was repeated 30 rain later. 
In Group 2B (6 patients),  following the initial gastroscopy, two 325-mg 
aspirin tablets were administered with 1-2 oz water. Another 650 rng dose 
was given 90 min later. Two hours after the first aspirin dose, gastroscopy 
and photography were again performed. 
Gastric aspirations were not performed prior to endoscopy. Two examiners 
individually recorded their endoscopic impression. After processing, the 
photographs were coded and the photographic interpretation was compared 
with the recorded impression. No significant discrepancies occurred. A 
gastroscopy was considered abnormal when hemorrhage, petechiae, or 
ecchymoses were present. Erythema was not considered abnormal because 
this was an inconsistent finding from endoscopist to endoscopist. 
*Acetylsalicylic acid, 325 mg. with 10% starch filler. 
~'Searle g: Company, Chicago, Ill. 
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RESULTS 
F E C A L  BLOOD L o s s  
Valid data were obtained in 17 of the 19 subjects studied in Group 1 (Table  
1). In  Subject T,K., hemolysis occurred, making  est imation of fecal blood 
lo~s impossible. In  all others, normal  decay curves for chromium-51 were 
obtained. One subject (L.C.) developed an episode of epistaxis on the last 
day of the control period, inval idat ing his fecal blood studies. Another  sub- 
ject (R.V.) was given a placebo dur ing the test period. His data are listed 
on the bo t tom of Tab l e  1. T w o  subjects (J.L. and D.B.) were given a 
charcoal marker  to determine how rapidly the material  from the stomach 
would be found in the feces. This  appeared in the stool at 24 and 36 hr, 
respectively, after adntinistration. At no time dur ing the test period did any 
subject complain  of distress. No gross blood was seen in an}, stool collection. 
Results of the fecal blood to~s studies are shown in the graph (Fig 1). The  
-Aspmn 640mg gld - 
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F i g  1. I)ail~ m e a n  fecal b lood  h,~s in II; n m m a l  subjects .  
mean 24-hr fecal blood loss dur ing tile control period was 0.38 -+- 0.35 (1 SD) g 
blood. However,  t int ing the period o[ aspirin administrat ion,  the 24-hr mean 
fecal blood loss rose to 1.:54 ± 1.t2 (1 SD) .,o blood. Tile mean fecal blood loss 
on Day, 1 of tile control period was less than I).25 ~_o,/')4 hr with a loss of 0.50 .g/ 
2 t  hr on Day 3 of the control period. When  Student 's  T-iest  is applied to the 
data, this difference is significant (p = < 0.01). We have no explanat ion for 
this increase, a l though it may have been due to gastroscopy. T o  test this 
hypothesis, 5 addit ional  normal  subjects were studied in the sanle manner  
excluding endoscopy. T h e  results reveal a mean 2 l-hr fecal blood loss during 
the control period of 0.32 ± 0.02 (1 SD) g/24 hr and a rise to 1AI ___ (I.23 
(1 SD) g/2-t hr dur ing the test period. When  tlm T-test is appl ied to the blood 
loss data of Day 3 for the group who had endoscopy and the group who did 
not have endoscopy, the difference is not significant (p = > 0.40). 
T h e  mean fecal blood loss increases dur ing the control period was sig- 
nificant (p = < 0.01). I1 we exclude in our  calculations, Subject E.A.. who 
bled the greatest amount ,  the ntean increase in the fecal blood los~ durin( x 
the control period is still highly significant (p = < 0.01). 
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(}AS'I'RObCOPIC STUDIES 
Group 1. Eighteen of the nineteen coim-ol gastroscopie, were interpreted 
as normal  by the two endoscopists. Ti le  only subject (F.H.) whose control 
gastroscopy was compat ible  with a diffuse gastritis ingested a modera te  amount  
of alcohol dur ing the 24 hr pr ior  to admission. His gastroscopy following 
aspirin adnfinistration was coinpletely normal.  Subject J.L. ingested 40 g 
of aspirin for approximate ly  1 week for a "head cold" but  had discontinued 
his aspirin intake 4 days prior  to the ini t iat ion of this study. T h e  endoscopic 
examinat ion o[ his stomach was norlnal. Of the 19 subjects, 5 (R.S., S.H., 
T.(; . ,  A.P., and R.C.) showed abnormali t ies  on the gastroscopic examinat ion  
when compared  with the control exaininat ion (Table  1). Of  the 5, 4 had 
mucosal petechiae (Fig 2) and 1 had a diffuse hemorrhagic  gastritis of the 
Fig 2. Subject R.C. Post. 
aq)irin ~iew of gastric antrunl  
with angulus and lesser curva- 
ture to right; 3 distinct pete- 
thiae are seen just left of 
angulus. 
entire visualized stomach. This  subject was tile only one who showed gross 
bleeding. Of tile four with petechiae, 3 had their lesions on the lesser curva- 
ture of the antrun~; the other had petechiae on the greater  curvature o[ the 
antrum. The  other 14 subjects had compleely normal  gastroscopies. Aspir in 
particles adherent  to the mucosa or the mucous lakes were frequently seen. 
When these particles were identified we were unable  to demonstra te  ab- 
normali ty of the mucosa s~u'rounding the adherent  particles. 
Group 2A. One subject demonstrated hyl)eremic changes 1-2 m m  in diam- 
eter on the lesser curvature of the gastric antrum, but no bleeding points or 
mucosal erosions were found. In all tlm subjects o[ this group, it was possible 
to delnonstrate particles o[ aspirin dissolved in tile lntlcous lake or small to 
medium particles of aspirin adhering tenaciously to the mucosa. Occasionally 
a partially dissolved tablet lying again,~t the gastric mucosa was seen, but  it 
was not possible to demonstrate  any hyperemia,  hemorrhage,  or erosions 
either immediately  adjacent to the aspirin particles or elsewhere in the 
stomach. 
Group 2B. Of tile 6 patients, 2 showed slight hyperemia  near the flecks of 
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aspirin in the lnucosa. Again it was not possible to lind hemorrhages or 
mucosal erosions in the stomach. 
BLOOD SAL1CYLATE LEVELS 
Of the 19 subjects in Group l, 18 had daily blood salicylate level determina- 
tions. In all cases, the blood level was measured about 8 hr after administra- 
tion of the last 650-nig aspirin dose. The  blood salicylate levels ranged from 
2.4 to 10.8 rag/100 ml. In those 5 subjects who showed abnormalities at 
gastroscopy, the blood salicylate level ranged from 3.0 mg to 8.2 mg/100 ml. 
BLOOD GROUPS 
in  Group 1 the ABO blood group distr ibution consisted of: 
Expected 
Blood Distribution distribution v~ 
group .Vo. (re) ( cz, c) 
A 10 52.6 39.2 
0 6 31.5 42.2 
AB 2 10.5 13.5 
B 1 5 .2  5.1 
Of the 5 subjects with gastroscopic abnormalities, 4 were of blood Group A, 
the other had blood Group O. Because our populat ion was weighed with 
subjects in blood Group  A, we were unable to find a valid correlation between 
the magnitude of fecal blood loss and a single blood group. 
PROTHROMBIN CONCENTRATION 
All the subjects in Group 1 had control pro thrombin  level determinations. 
Of the 19, 9 had protlu 'ombin deternIinations during the. test. No significant 
change of the pro tbrombin  concentrat ion was found during the test period. 
DISCUSSION 
GASFROSCOPIC STUDIES ]7OLLO~,VING ASPIRIN ADMINISTRATION 
Multiple gastroscopic studies following aspirin therapy have been per- 
formed. Due to the variations in experimental  design and individual interpreta- 
tion of the underlying disease process involving the stomach, the results are 
often conflicting. Douthwaite  and Lintot t  I reported that 13 out of 16 patients 
revealed abnormalities consisting of slight hyperemia to submucosal hemorrhage 
following the ingestion of 15 g of crushed aspirin. However, they did not 
perform control gastroscopies and tile)' aspirated tile stomach prior to 
gastroscopy. Our  experience indicates that vigorous aspiration prior to 
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gastroscopy ilia) produce submucosal  hemorrhage.  Weiss et al" performed 
control gastroscopies but  included an aspirat ion as par t  of  their preparat ion.  
They  found abnormali t ies  in 13 out of 30 patients  studied within 15 rain of 
the adminis trat ion of 15 g aspirin. Caravati  and Cosgrove 3 studied the 
effect of oral aspirin and intravenous sodium salicylate on 20 patients. Wi th  
blood levels of 30 mg/100 ml, only I pat ient  showed a superficial gastritis. 
With a gastroscope ill place, Vickers ~ administered 650 mg asp i r in / tube  to 
70 patients and observed the effects for up to 35 rain; he found lesions in 
12 patients. Whether  or not a pre-endoscopic aspirat ion was per formed on his 
patients is unclear. 
Thorsen  et at 5 using the gastrocamera, administered 600 mg  of aspirin to a 
group of healthy volunteers and varied the p H  of the gastric contents. They  
showed that the abnormal i ty  seen at gastroscopy was related to the low intra- 
gastric pH.  Howe+er, these authors had aspirated the stomach prior  to 
endoscopic examinat ion.  
T h e  lesions repor ted by these authors have been described as varying f rom 
small petechial hemorrhages to frank erosive and hemorrhagic  gastritis oc- 
curring pr imari ly  along the lesser curvature of the ant rum.  In  contrast, 
however, are the reports of Paul  G and Rider  7 who found no endoscopic evi- 
dence incr iminat ing aspirin as a cause of such lesions. 
In  our  Group  1 subjects, 5 of 19 revealed abnormali t ies  which we at t r ibute  
to the aspirin ingestion, in  the Group  2 subjects, there were no abnormali t ies  
which we could a t t r ibute  to the aspirin. Al though Groups  1 and 2 are not  
comparable,  the presence of pre-existing disease within the stomach did not 
seem to influence the occurrence of visible lesion. 
In  many  of our subjects, the aspirin could be seen as an incompletely dis- 
solved tablet or as large or small flecks adhering to the mucosa. No sur- 
rounding abnormal i ty  was observed except in the pat ient  who demonstra ted  
hemorrhagic gastritis. However,  this does not rule out lesions undernea th  the 
aspirin as it could not be "wiped away" with the scope. Our  study is some- 
what l imited because of the l imitat ions of the G T F  gastrocamera which do 
not permit  good visualization of the gastric fundus. But  all previous reports  
indicate that the lesions occur on the lesser curve of the ant rum,  and fre- 
quently lesions are scattered throughout  the gastric mucosa. 5 Fur thermore ,  
where the gastrocamera was used to visualize tlm cardia of the stomach, 
ecchymoses were disregarded in this area because they were a t t r ibuted to 
ins t rument  t rauma.  5 
FECAL BLOOD Loss FOLLOWING ASPIRIN ADMINISTRATION 
Our  control fecal blood loss values of 0.38 ± 0.35 g /24  hr (1 SD) are in 
agreement with those of other authors who used the chromium-51 method.  
Our  data are given in grams of blood lost. Wint robe  13 states that  the specific 
gravity of normal  blood ranges fi'om 1.048 to 1.066. Conver t ing our  weights 
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to volmne, our  blood loss levels arc slightly lower than those of others. Hol t  ~ 
found 0.41 ml  blood in the 2-t-hr stool in 10 normal  vohtnteers. Croft and 
Wood,/4 in studying 226 subjects with no known gastrointestinal disease, found 
a mean blood loss of 0.6 ml /24  hr. Pierson ~0 found a mean 24-hr fecal blood loss 
in normal  people  of 0.5 nil for 24 hr, and Bouchier and Will iams ~ found a 
24-hr mean loss of 0.36 nfl in healthy subjects. 
Dur ing  the per iod of a spMn adnfinistration, we found a mean fecal blood 
loss of 1.54 g/24 hr. Pierson el al ~° found 4.7 ± -t.1 ml fecal blood loss during 
adminis t ra t ion of 600 mg of aspirin four times daily. Hol t  '° found a mean 
24-hr fecal blood lo~s of 5.72 ml dur ing the oral adminis trat ion of 600 mg 
of aspirin four tilnes daily for 6 days to heal thy vohmteers.  Our  lower values 
might  be due to the fact that  we assayed feces during a 4-day period of 
aspirin adminis t ra t ion while these authors administered aspirin for 6 days 
and init iated fecal collections on Day 4 of drug administrat ion.  I t  is probable  
that  collection of the stool after the blood loss had  been established for 
several days accounted for the difference, as we collected our specimens during 
the establ ishment  of blood loss. 
Al though visible gastroscopic abnormali t ies  were noted in only 5 of 19 
subjects in Groul~ 1, this does not rule out the possibility that gastric mt|cosal 
lesions were present at other points in time, since gastroscopy and gas|to- 
photography  view the stomach for a brief finite period of time. I f  indeed, one 
could say with certainty that  all stomachs were unremarkable  at all times 
dur ing the test period, one might  speculate that perhaps the fecal blood loss 
originated elsewhere in the gastrointestinal tract. T h e  stomach may not be 
the som'ce of the bleeding but addit ional  work is needed to answer this 
question. 
No correlation betwee|! the changes in prothroml)in concentrat ion or blood 
salicylate levels and fecal blood loss was fomld. 
CORREL),TION Ol: T n l :  (~ASTROSCOPIC FINDINGS AND lgECAI. 11I,OOI) Loss 
Subjects R.5., S.H., T.(; . .  A.P., and R.C. demonstra ted almormali t ies  on 
endoscopic examinat ion.  Thex lost respectively 0.83, 2.-12, 0.17, 2.2-1, and 0.78 g 
ot blood dur ing the aspirin-ingestion period. These values fall well within 
one s tandard deviation ol o | | |  mean fecal blood loss and are equal to or below 
the greatest blood loss levels that were tot,nd in subjects E.A., B.G., and 
F.H., who had normal  gastroscopic tindings. I t  thus appears that under  thc 
conditions of our study, the increased fecal blood loss following aspirin 
therapy is | |o|  correlated with gro~sl) visible gastric lesions. 
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